Cardiac failure congestive and drugs of ingredients of sodium nitroprusside - a phase IV clinical study of FDA data
Cardiac failure congestive is found among people who take drugs with ingredients of sodium nitroprusside, especially for people who are female, 60+ old . This phase IV clinical study is created by eHealthMe based on reports of 985 people who have side effects when taking drugs with ingredients of sodium nitroprusside from the FDA, and is updated regularly.
Drug(s) considered in the study (i.e. both brand name and generic drugs): Nipride, Nipride rtu in sodium chloride 0.9%, Nitropress, Sodium nitroprusside.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
985 people reported to have side effects when taking drugs with ingredients of sodium nitroprusside.
Among them, 30 people (3.05%) have Cardiac failure congestive
What is Cardiac failure congestive?
Cardiac failure congestive is found to be associated with 2,883 drugs and 2,099 conditions by eHealthMe.
Number of reports submitted per year:
Gender of people who have Cardiac failure congestive when taking drugs with ingredients of sodium nitroprusside *:
- female: 63.33 %
- male: 36.67 %
Age of people who have Cardiac failure congestive when taking drugs with ingredients of sodium nitroprusside *:
- 0-1: 9.52 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 14.29 %
- 60+: 76.19 %
Conditions people have *:
- High Blood Pressure: 3 people, 10.00%
- Ill-Defined Disorder: 2 people, 6.67%
- Diabetes: 2 people, 6.67%
- Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 1 person, 3.33%
- Lung Neoplasm Malignant (cancer tumour of lung): 1 person, 3.33%
- Hypertension Neonatal (high blood pressure in neonatal): 1 person, 3.33%
- Fluid Retention (an abnormal accumulation of fluid in the blood): 1 person, 3.33%
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 3.33%
Other drugs people take *:
- Lasix: 24 people, 80.00%
- Digoxin: 19 people, 63.33%
- Lopressor: 13 people, 43.33%
- Morphine: 13 people, 43.33%
- Lidocaine: 12 people, 40.00%
- Lisinopril: 11 people, 36.67%
- Plavix: 11 people, 36.67%
- Nitroglycerin: 11 people, 36.67%
- Synthroid: 10 people, 33.33%
- Lantus: 10 people, 33.33%
Other side effects people have besides Cardiac failure congestive *:
- Hypotension (abnormally low blood pressure): 13 people, 43.33%
- Pain: 12 people, 40.00%
- Breathing Difficulty: 12 people, 40.00%
- High Blood Pressure: 11 people, 36.67%
- Fatigue (feeling of tiredness): 11 people, 36.67%
- Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 11 people, 36.67%
- Pleural Effusion (water on the lungs): 11 people, 36.67%
- Atelectasis (partial or complete collapse of the lung): 10 people, 33.33%
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 10 people, 33.33%
- Chest Pain: 10 people, 33.33%
* Approximation only. Some reports may have incomplete information.
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Drugs with ingredients of sodium nitroprusside, their effectiveness, alternatives and more:
How the study uses the data?
The study uses data from the FDA. It is based on sodium nitroprusside. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Prednisolone and Leukaemic Infiltration - a second ago
- How effective is Celebrex for Fibromyalgia? - 3 seconds ago
- Carboplatin and Depilation - 19 seconds ago
- Milnacipran Hydrochloride and Magnesium Oxide drug interaction - 22 seconds ago
- Baclofen and Aimovig drug interaction - 25 seconds ago
- Exemestane and Hip Joint Replacement - 44 seconds ago
- Pepcid Ac and Kidney Malformation - 44 seconds ago
- Prevacid and Aptivus drug interaction - 48 seconds ago
- Tribenzor and Hangover - 49 seconds ago
- Alendronate Sodium and Dexilant drug interaction - 50 seconds ago